ADIM
GMED icon

Alpha DNA Investment Management’s Globus Medical GMED Stock Holding History

Alpha DNA Investment Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3
Closed – – 317
2021
Q1 		$0 Sell
3
-12,662
-100% -$802K ﹤0.01% 727
2020
Q4 		$826K Buy
+12,665
New +$728K 0.88% 35

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Alpha DNA Investment Management's GMED Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Globus Medical (GMED) in Q2 2021, closing a stake of 3 shares.

Alpha DNA Investment Management first reported a position in GMED in Q4 2020 and held it in 2 quarters. The position peaked at $826K in Q4 2020. 354 funds tracked by Wall St. Rank hold GMED as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Globus Medical position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3 Globus Medical shares in Q2 2021.
  • Alpha DNA Investment Management first reported a position in Globus Medical in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Globus Medical position peaked at $826K in Q4 2020.
  • 354 funds tracked by Wall St. Rank held Globus Medical as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.